Login / Signup

What we know about effective public engagement on CRISPR and beyond.

Dietram A ScheufeleNicole M KrauseIsabelle FreilingDominique Brossard
Published in: Proceedings of the National Academy of Sciences of the United States of America (2021)
Advances in gene editing technologies for human, plant, and animal applications have led to calls from bench and social scientists, as well as a wide variety of societal stakeholders, for broad public engagement in the decision-making about these new technologies. Unfortunately, there is limited understanding among the groups calling for public engagement on CRISPR and other emerging technologies about 1) the goals of this engagement, 2) the modes of engagement and what we know from systematic social scientific evaluations about their effectiveness, and 3) how to connect the products of these engagement exercises to societal decision or policy making. Addressing all three areas, we systematize common goals, principles, and modalities of public engagement. We evaluate empirically the likely successes of various modalities. Finally, we outline three pathways forward that deserve close attention from the scientific community as we navigate the world of Life 2.0.
Keyphrases
  • healthcare
  • social media
  • mental health
  • decision making
  • crispr cas
  • randomized controlled trial
  • systematic review
  • endothelial cells
  • genome editing
  • emergency department
  • working memory
  • adverse drug
  • body composition